Diagnostic dilemma in a case of jaundice complicating pregnancy with successful maternal outcome in a tertiary care centre
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252358Keywords:
Acute fatty liver in pregnancy, Disseminated intravascular coagulation, Intra-hepatic cholestasis of pregnancy, Jaundice in pregnancy, Multidisciplinary team approachAbstract
Approximately 3% of all pregnancies are complicated by liver biochemical test abnormalities, the most life-threatening of which is acute fatty liver of pregnancy (AFLP). We report a case of 32 years G2A1 patient, with IVF conceived DCDA twin pregnancy at 30+3 weeks gestation with intra-uterine death of one fetus with preterm prelabour rupture of membrane with meconium-stained liquor along with a history of jaundice from her 5th month of gestation. Her biochemical parameters were suggestive of early signs of disseminated intravascular coagulation. Acute fatty liver of pregnancy was suspected while keeping in mind other differentials and the patient was managed by prompt delivery and a multi-disciplinary team approach. High index of suspicion of the condition in women presenting with jaundice in pregnancy, can prevent maternal mortality and morbidity.
Metrics
References
Ellington SR, Flowers L, Legardy-Williams JK, Jamieson DJ, Kourtis AP. Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010. Am J Obstet Gynecol. 2015;212(4):524. DOI: https://doi.org/10.1016/j.ajog.2014.10.1093
Ch’ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51(6):876–80. DOI: https://doi.org/10.1136/gut.51.6.876
Ibdah JA. Acute fatty liver of pregnancy: An update on pathogenesis and clinical implications. World J Gastroenterol WJG. 2006;12(46):7397–404. DOI: https://doi.org/10.3748/wjg.v12.i46.7397
Joueidi Y, Peoc’h K, Le Lous M, Bouzille G, Rousseau C, Bardou-Jacquet E, et al. Maternal and neonatal outcomes and prognostic factors in acute fatty liver of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020;252:198–205. DOI: https://doi.org/10.1016/j.ejogrb.2020.06.052
Liu J, Ghaziani TT, Wolf JL. Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis and Management. Am J Gastroenterol. 2017;112(6):838–46. DOI: https://doi.org/10.1038/ajg.2017.54
Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340(22):1723–31. DOI: https://doi.org/10.1056/NEJM199906033402204
Wong M, Hills F, Vogler K, Zardawi I, Nandi N. Acute Fatty Liver of Pregnancy From 18 Weeks’ Gestation. Hepatol Baltim Md. 2020;71(6):2167–9. DOI: https://doi.org/10.1002/hep.31090
Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr. 2010;30:237–55. DOI: https://doi.org/10.1146/annurev.nutr.012809.104742
Nelson DB, Byrne JJ, Cunningham FG. Acute Fatty Liver of Pregnancy. Clin Obstet Gynecol. 2020;63(1):152–64. DOI: https://doi.org/10.1097/GRF.0000000000000494
Vigil-de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment and outcome based on 35 consecutive cases. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2011;24(9):1143–6. DOI: https://doi.org/10.3109/14767058.2010.531325
Allison MG, Shanholtz CB, Sachdeva A. Hematological Issues in Liver Disease. Crit Care Clin. 2016;32(3):385–96. DOI: https://doi.org/10.1016/j.ccc.2016.03.004
Alam A, Choi S. Prophylactic Use of Tranexamic Acid for Postpartum Bleeding Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Transfus Med Rev. 2015;29(4):231–41. DOI: https://doi.org/10.1016/j.tmrv.2015.07.002
Downloads
Published
How to Cite
Issue
Section
